Since opening its first European manufacturing site in 1990, Dell Technologies has been contributing to the continent’s extensive technology ecosystem in everything from fostering digital skills to shoring up its supply of components and providing infrastructure. Advancing that legacy, it recently opened two cutting-edge technology testing and research centres to help Europe realise its advanced manufacturing potential. The Customer Solution Centre Innovation Lab in Limerick showcases solutions for real-world use cases and enables businesses to unlock the power of emerging technologies. At the recently re-developed Dell Technologies Customer Solution Centre in Cork, businesses can test drive their datasets and workloads prior to deployment, gaining valuable hands-on experience before going live. Through these facilities, Dell is doing its part to position Europe as a global technology hub.
Invested in Europe: fostering advanced manufacturing with Dell
Since opening its first European manufacturing site in 1990, Dell Technologies has been contributing to the continent’s extensive technology ecosystem in everything from fostering digital skills to shoring up its supply of components and providing infrastructure. Advancing that legacy, it recently opened two cutting-edge technology testing and research centres to help Europe realise its advanced manufacturing potential. The Customer Solution Centre Innovation Lab in Limerick showcases solutions for real-world use cases and enables businesses to unlock the power of emerging technologies. At the recently re-developed Dell Technologies Customer Solution Centre in Cork, businesses can test drive their datasets and workloads prior to deployment, gaining valuable hands-on experience before going live. Through these facilities, Dell is doing its part to position Europe as a global technology hub.
Related items
:focal())
Strengthening Europe’s cybersecurity framework through simplification
The review of the Cybersecurity Act (CSA 2.0) is an opportunity to build a more coherent, outcome-oriented EU cybersecurity framework. While the proposal recognises fragmentation across the Single Market, further simplification is needed to reduce overlaps and support effective compliance.
A harmonised approach to risk assessment and supervision can strengthen resilience while avoiding duplicative obligations. Certification and supply-chain measures should remain risk-based, objective, technical and aligned with international standards. Structured industry engagement and clear designation thresholds under the ICT Supply Chain Framework and a secure-by-design approach to policymaking will be essential to support cybersecurity and global interoperability. Read more on how CSA 2.0 can strengthen resilience across the Single Market.
:focal())
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.